Previous close | 173.94 |
Open | 174.85 |
Bid | 176.70 x 1000 |
Ask | 176.61 x 1200 |
Day's range | 174.07 - 177.15 |
52-week range | 155.72 - 186.69 |
Volume | |
Avg. volume | 7,784,985 |
Market cap | 465.918B |
Beta (5Y monthly) | 0.72 |
PE ratio (TTM) | 26.45 |
EPS (TTM) | 6.69 |
Earnings date | 18 Apr 2022 - 22 Apr 2022 |
Forward dividend & yield | 4.52 (2.56%) |
Ex-dividend date | 23 May 2022 |
1y target est | 191.42 |
The Health Care Select Sector SPDR ETF and Johnson and Johnson have been highlighted in this Investment Ideas article.
This sector outperformance may be a sign the market is nearing a point of selling exhaustion.
Shares of Johnson & Johnson (NYSE: JNJ) climbed higher this morning and are trading up 2.2% as of 11 a.m. ET. The healthcare giant received a thumbs-up from an analyst, who sees roughly 14% upside in Johnson & Johnson stock from yesterday's close. Analyst David Risinger from healthcare-focused investment bank SVB Leerink gave Johnson & Johnson stock an outperform rating with a price target of $200 per share, according to TheFly.com.